He, B., Chen, H., Wu, J., Qiu, S., Mai, Q., Zeng, Q., . . . Xu, N. (2025). Interleukin-21 engineering enhances CD19-specific CAR-NK cell activity against B-cell lymphoma via enriched metabolic pathways. Experimental Hematology & Oncology, 14(1), 1. https://doi.org/10.1186/s40164-025-00639-2
Chicago-referens (17:e uppl.)He, Bailin, et al. "Interleukin-21 Engineering Enhances CD19-specific CAR-NK Cell Activity Against B-cell Lymphoma via Enriched Metabolic Pathways." Experimental Hematology & Oncology 14, no. 1 (2025): 1. https://doi.org/10.1186/s40164-025-00639-2.
MLA-referens (9:e uppl.)He, Bailin, et al. "Interleukin-21 Engineering Enhances CD19-specific CAR-NK Cell Activity Against B-cell Lymphoma via Enriched Metabolic Pathways." Experimental Hematology & Oncology, vol. 14, no. 1, 2025, p. 1, https://doi.org/10.1186/s40164-025-00639-2.
